America September 27, 2025
Cellectis, AstraZeneca Hit with IP Suit Over Gene-Editing Technology
A Massachusetts-based biotech says two pharmaceutical giants are trampling its intellectual property. Factor Bioscience Inc. filed suit Friday in Delaware…